关键词:

脑梗死, 急性, 个性化护理, 丁苯肽, 血流动力学, 神经功能, 认知功能

Abstract:

Objective　To analyze the application effect of in patients with acute cerebral infarction treated with butylphenylene peptide. Methods　Nine-six patients with acute cerebral infarction treated at Shangqiu First People's Hospital from June 2022 to May 2023 were selected for the retrospective study. According to the nursing methods, the patients were divided into a reference group and an experimental group, with 48 cases in each group. There were 25 males and 23 females in the reference group; they were (62.58±8.14) years old; the onset time was (4.12±1.21) h. There were 27 males and 21 females in the experimental group; they were (62.51±8.23) years old; the onset time was (4.09±1.23) h. Both groups were treated with butylphenylene peptide. The reference group took routine care. The experimental group took personalized care, including psychological care, rehabilitation care, dietary guidance, medication care, and health education. The drug therapy and nursing intervention lasted for 14 d in both groups. The scores of National Institutes of Health Stroke Scale (NIHSS) and Simple Mental status Checklist (MMSE), intracranial arterial hemodynamics, and quality of life before and after the intervention and nursing satisfaction were compared between the two groups. t and χ² tests were used for the statistical analysis. Results　After the intervention, the scores of NIHSS and MMSE in the experimental group were better than those in the reference group (13.05±1.12 vs. 19.49±1.73 and 26.05±2.32 vs. 20.01±1.92), with statistical differences (both P<0.05). The vascular pulsation index (PI), vascular resistance index (RI) systolic peak blood flow velocity (PSV), and end-diastolic blood flow velocity (EDV) in the experimental group were lower than those in the reference group [(1.35±0.12)% vs. (1.49±0.23)%, (0.95±0.11)% vs. (1.04±0.15)%, (87.72±6.23) cm/s vs. (79.80±5.81) cm/s, and (22.02±2.23) cm/s vs. (19.76±2.61) cm/s, with statistical differences (all P<0.05). The scores of physiological function, physiological function, physical pain, general health, vitality, social function, emotional function, and mental health in the experimental groups were higher than those in the reference group (78.01±4.26 vs. 71.46±4.34, 80.02±4.23 vs. 73.41±4.36, 85.37±4.29 vs. 77.42±4.45, 83.61±4.25 vs. 76.51±4.31, 84.01±4.21 vs. 75.72±4.31, 85.91±4.21 vs. 74.65±4.31, 86.08±4.22 vs. 76.35±4.52, and 88.05±4.52 vs. 77.10±4.41), with statistical differences (all P<0.05). The nursing satisfaction of the experimental group was higher than that of the reference group [95.83% (46/48) vs. 77.08% (37/48)], with a statistical difference (P<0.05). Conclusion　Personalized nursing intervention for patients with acute cerebral infarction treated with butylphenylene peptide can not only improve their neurological function and cognitive function, but also optimize their intracranial arterial hemodynamics and improve their quality of life and satisfaction with nursing services.

Key words:

Acute cerebral infarction, Personalized nursing, Butylphenylene peptide, Hemodynamics, Nerve function, Cognitive function